Carisma Therapeutics, Inc.
USD0.00
+0.00 (+0.00%)
CEO
Saar Gill
IPO Date
2014-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.03
52W Low
$0.00
52W High
$1.27
Market Cap
$0.00B
Volume
0.01M
| 56,982 |
| $0.25 |
| 8 Oct 2025 | Klichinsky Michael | Chief Scientific Officer | M-Exempt | Disposed | 56,982 | $0.11 |
| 3 Oct 2025 | Klichinsky Michael | Chief Scientific Officer | S-Sale | Disposed | 165,000 | $0.26 |
| 3 Oct 2025 | Klichinsky Michael | Chief Scientific Officer | S-Sale | Disposed | 200,000 | $0.25 |
| 3 Oct 2025 | Klichinsky Michael | Chief Scientific Officer | S-Sale | Disposed | 119,347 | $0.26 |
| 30 Jan 2025 | Kelly Steven | director, officer: President and CEO | A-Award | Acquired | 500,000 | $0.50 |
| 1 Jul 2024 | Thorell Marella | director | A-Award | Acquired | 38,700 | $1.67 |
| 1 Jul 2024 | Thorell Marella | director: | Disposed | 0 | $0.00 |
| 1 Jul 2024 | Scadden David | director | A-Award | Acquired | 38,700 | $1.67 |